Clinical Trials

Showing trials with last updates posted in 2018.

NCT01323621 | COMPLETED | PHASE3
512 participants
NCT01058239 | COMPLETED | PHASE2
7 participants

Bortezomib Plus Rituximab for EBV+ PTLD

Study Type:
INTERVENTIONAL
Last Updated:
2018-02-15
Start Date:
2011-11-30
Completion:
2016-12-31
Conditions
  • Post-transplant Lymphoproliferative Disease
  • Solid Organ Transplant
  • Stem Cell Transplant (Bone Marrow Transplant)
  • Epstein Barr Virus Infections
Interventions
  • DRUG
NCT00852709 | TERMINATED | PHASE1
35 participants

Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias

Study Type:
INTERVENTIONAL
Last Updated:
2018-02-15
Start Date:
2007-09-01
Completion:
2009-11-20
Conditions
  • Myelodysplastic Syndrome
  • Acute Myeloid Leukemia
  • Myeloproliferative Disorders
  • Acute Lymphocytic Leukemia
  • Acute Promyelocytic Leukemia
  • Acute Leukemia
  • Chronic Myelogenous Leukemia
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Juvenile Myelomonocytic Leukemia
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page